Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-12

FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for sotalol hydrochloride from Oxford Pharmaceuticals, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sotalol hydrochloride (sotalol hydrochloride)

Snippet

SUPPL AP for SOTALOL HYDROCHLORIDE (SOTALOL HYDROCHLORIDE)